34404300 35318780 35521735 36108649 36891589 35136579 32060150 36485165 33150384 35521734 32293786 31353761 31846611 35910942 34764641 32597029 32469134 32746496 36855941 35185895 - Search Results

Year	Number of Results
2019	2
2020	5
2021	5
2022	8
2023	2

1

An update of the current pharmacotherapeutic armamentarium for hemophilia A.

Mahlangu J. Mahlangu J. Expert Opin Pharmacother. 2022 Jan;23(1):129-138. doi: 10.1080/14656566.2021.1961742. Epub 2021 Aug 18. Expert Opin Pharmacother. 2022. PMID: 34404300

2

A preliminary application of a haemophilia value framework to emerging therapies in haemophilia.

Skinner MW, Dolan G, Eichler H, O'Mahony B; International Haemophilia Access Strategy Council. Skinner MW, et al. Haemophilia. 2022 Mar;28 Suppl 2:9-18. doi: 10.1111/hae.14511. Haemophilia. 2022. PMID: 35318780 Review.

3

Managing invasive procedures in haemophilia patients with limited resources, extended half-life concentrates or non-replacement therapies in 2022.

Mancuso ME, Apte S, Hermans C. Mancuso ME, et al. Haemophilia. 2022 May;28 Suppl 4:93-102. doi: 10.1111/hae.14551. Haemophilia. 2022. PMID: 35521735

4

The More Recent History of Hemophilia Treatment.

Franchini M, Mannucci PM. Franchini M, et al. Semin Thromb Hemost. 2022 Nov;48(8):904-910. doi: 10.1055/s-0042-1756188. Epub 2022 Sep 15. Semin Thromb Hemost. 2022. PMID: 36108649 Review.

5

New directions to develop therapies for people with hemophilia.

Gogia P, Tarantino M, Schramm W, Aledort L. Gogia P, et al. Expert Rev Hematol. 2023 Jun;16(6):417-433. doi: 10.1080/17474086.2023.2184341. Epub 2023 Mar 8. Expert Rev Hematol. 2023. PMID: 36891589 Review.

6

Efficacy, safety, and immunogenicity of rurioctocog alfa pegol for prophylactic treatment in previously treated patients with severe hemophilia A: a systematic review and meta-analysis of clinical trials.

Witarto BS, Visuddho V, Witarto AP, Sutanto H, Wiratama BS, Wungu CDK. Witarto BS, et al. F1000Res. 2021 Oct 15;10:1049. doi: 10.12688/f1000research.73884.3. eCollection 2021. F1000Res. 2021. PMID: 35136579 Free PMC article.

7

Hemophilia therapy: the future has begun.

Mannucci PM. Mannucci PM. Haematologica. 2020 Mar;105(3):545-553. doi: 10.3324/haematol.2019.232132. Epub 2020 Feb 14. Haematologica. 2020. PMID: 32060150 Free PMC article. Review.

8

Perioperative hemostasis for patients with hemophilia.

Poston JN, Kruse-Jarres R. Poston JN, et al. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):586-593. doi: 10.1182/hematology.2022000387. Hematology Am Soc Hematol Educ Program. 2022. PMID: 36485165 Free PMC article. No abstract available.

9

Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study.

Klamroth R, Windyga J, Radulescu V, Collins PW, Stasyshyn O, Ibrahim HM, Engl W, Tangada SD, Savage W, Ewenstein B. Klamroth R, et al. Blood. 2021 Apr 1;137(13):1818-1827. doi: 10.1182/blood.2020005673. Blood. 2021. PMID: 33150384 Free PMC article. Clinical Trial.

10

Into a brave new world: Haemophilia A & von Willebrand Disease Surgery with novel therapies.

Harrison C, Chase J, Fawcett K, Shoemark R, Valderrama Y. Harrison C, et al. Haemophilia. 2022 May;28 Suppl 4:125-131. doi: 10.1111/hae.14543. Haemophilia. 2022. PMID: 35521734 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year